BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Somatic Cell Gene Editing - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://scge.mcw.edu
X-WR-CALDESC:Events for Somatic Cell Gene Editing
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Chicago
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20220313T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20221106T070000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20230312T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20231105T070000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20240310T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20241103T070000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20230129
DTEND;VALUE=DATE:20230202
DTSTAMP:20260410T182029
CREATED:20221020T162656Z
LAST-MODIFIED:20221020T162656Z
UID:2680-1675015200-1675274399@scge.mcw.edu
SUMMARY:3rd TGF-β for Immuno-Oncology Drug Development Summit
DESCRIPTION:In the past year alone\, the field has learnt valuable lessons from the clinical trials and from the wider TGF-β field that will equip the immuno-oncology field with the knowledge needed to supercharge future TGF-β monotherapy or combinational therapeutics for precision medicine. \nFrom uncovering the effects and production of TGF-β in immune\, tumor and stromal cells to exploring predictive and pharmacodynamic TGF-β biomarkers for patient identification and assessing the clinical challenges that led to recent clinical failures\, the 3rd TGF-β for Immuno-Oncology Drug Development Summit is your one-stop-shop dedicated to harnessing you with the knowledge to unlock the potential of successfully targeting TGF-β. \nTailored with 18+ senior leaders\, the 2023 meeting will be taking place in-person for the first time – don’t miss your chance to be in the room for your comprehensive guide on TGF-β in immuno-oncology! \nWhether you are new to this field or a seasoned expert\, this meeting will provide you with the must-know takeaways from the basic biology to biomarkers to clinical trial design to overcome the clinical setbacks and produce a blockbuster TGF-β therapeutic.
URL:https://scge.mcw.edu/events/3rd-tgf-%ce%b2-for-immuno-oncology-drug-development-summit/
LOCATION:Marines’ Memorial Club & Hotel\, 609 Sutter St\, San Francisco\, CA\, 94102\, United States
ATTACH;FMTTYPE=image/png:https://scge.mcw.edu/wp-content/uploads/2022/10/Capture-6.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20230129
DTEND;VALUE=DATE:20230202
DTSTAMP:20260410T182029
CREATED:20221027T165045Z
LAST-MODIFIED:20221027T165045Z
UID:2763-1675015200-1675274399@scge.mcw.edu
SUMMARY:2nd Allogeneic Cell Therapies Summit Europe
DESCRIPTION:Allogeneic approaches are deemed the future of cell therapy due to their potential to reduce costs\, increase accessibility and enhance availability. However as clinical readouts emerge\, challenges associated with limited durability\, solid tumour targeting and therapy immunogenicity are hindering their efficacies. \nThe Allogeneic Cell Therapies Summit Europe is returning in January to capture the clinical advances of European drug developers whilst addressing the specific challenges they face in development. These include European regulatory affairs\, donor selection\, scalable manufacturing and therapy persistence. \nWith continued investment and growth in the allogeneic space\, join European leaders from Gadeta\, Antion Biosciences\, TC BioPharm\, and many more\, as well as the US leaders undertaking European trials. This includes Atara Bio and Adicet Bio\, as they progress development of multiple cell types to produce the next-generation of safe\, effective and accessible cell therapies in Europe.
URL:https://scge.mcw.edu/events/2nd-allogeneic-cell-therapies-summit-europe/
LOCATION:Leonardo Royal London City\, 8-14 Cooper's Row\, London\, EC3N 2BQ\, United Kingdom
ATTACH;FMTTYPE=image/png:https://scge.mcw.edu/wp-content/uploads/2022/10/Capture-25.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20230130
DTEND;VALUE=DATE:20230203
DTSTAMP:20260410T182029
CREATED:20221020T155358Z
LAST-MODIFIED:20221020T155527Z
UID:2665-1675101600-1675360799@scge.mcw.edu
SUMMARY:Viral Vector Process Development Summit
DESCRIPTION:As cell & gene therapy and genomic medicine pipeline continues to mature\, process development for viral vector is becoming critical for drug developers for the next phase\, to deliver a quality\, transformative cure to patients with affordability. The recent investments such as Novartis-Samsung Biologics $81m contract for viral vector manufacturing\, Resilience raising $625m towards biomanufacturing capabilities including stable cell lines for viral vector production pave the foundation for scientific and technology innovations. \nWith better understanding of these novel nanoparticles\, developability and cell line development\, the ability to optimize AAV\, LV formulation and define robust CQAs are critical to drug developers’ ability to increase scalability with efficiency\, reduce cost of goods and most importantly\, ensure product quality control for patients.
URL:https://scge.mcw.edu/events/viral-vector-process-development-summit/
LOCATION:Omni Parker House\, 60 School St\, Boston\, MA\, 02108\, United States
ATTACH;FMTTYPE=image/png:https://scge.mcw.edu/wp-content/uploads/2022/10/Capture-4.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20230213
DTEND;VALUE=DATE:20230217
DTSTAMP:20260410T182029
CREATED:20221110T172841Z
LAST-MODIFIED:20221110T172841Z
UID:2802-1676311200-1676570399@scge.mcw.edu
SUMMARY:5th Annual CRISPR AgBio Congress
DESCRIPTION:The 5th Annual CRISPR AgBio Congress will unite research heads\, molecular biologists\, regulatory experts\, and product developers who are involved in the journey from early R&D through to creating a marketable product. Perspectives will be shared from large Ag companies\, innovative AgBiotechs\, key academic groups\, regulatory bodies\, and independent institutions working to translate cutting-edge CRISPR technology into a tangible product.
URL:https://scge.mcw.edu/events/5th-annual-crispr-agbio-congress/
LOCATION:The Westin San Diego Bayview\, 400 W Broadway\, San Diego\, CA\, 92101\, United States
ATTACH;FMTTYPE=image/png:https://scge.mcw.edu/wp-content/uploads/2022/11/Capture-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20230214
DTEND;VALUE=DATE:20230217
DTSTAMP:20260410T182029
CREATED:20221027T163020Z
LAST-MODIFIED:20221027T163020Z
UID:2749-1676397600-1676570399@scge.mcw.edu
SUMMARY:6th Annual Cell & Gene Therapy Innovation Summit
DESCRIPTION:#CGTI 2023 will highlight the manufacturing challenges facing Cell & Gene Therapy\, bringing clear insights and industry best practices from renowned sector leaders. Achieve a deeper understanding of the many manufacturing and industrialization burdens unique to carrying durable and curative therapies to needy patients.
URL:https://scge.mcw.edu/events/6th-annual-cell-gene-therapy-innovation-summit/
LOCATION:Hotel Palace Berlin\, Budapester Str. 45\, Berlin\, 10787\, Germany
ATTACH;FMTTYPE=image/png:https://scge.mcw.edu/wp-content/uploads/2022/10/Capture-22.png
END:VEVENT
END:VCALENDAR